Clincosm LogoSign in Get a demo

Coronavirus

Showing NaN - NaN of 6
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

COVID-19, Coronavirus, SARS-CoV-2 Trial in United States (pathogen reduced SARS-CoV-2 convalescent plasma, Placebo)

Completed
Has Results
  • COVID-19
  • +2 more
  • pathogen reduced SARS-CoV-2 convalescent plasma
  • Placebo
  • Little Rock, Arkansas
  • +25 more
Oct 6, 2022

SARS (Severe Acute Respiratory Syndrome), Coronavirus Trial in Sweden, United States (Nitric Oxide Gas)

Completed
  • SARS (Severe Acute Respiratory Syndrome)
  • Coronavirus
  • Nitric Oxide Gas
  • Birmingham, Alabama
  • +4 more
Jun 20, 2022

Tumors, Coronavirus Trial in United States

Recruiting
  • Neoplasms
  • Coronavirus
    • Birmingham, Alabama
    • +84 more
    Feb 23, 2022

    Coronavirus, Acute Respiratory Infection, SARS-CoV Infection Trial in United States (Hydroxychloroquine, Placebo)

    Completed
    Has Results
    • Coronavirus
    • +2 more
    • Tucson, Arizona
    • +39 more
    Mar 12, 2021

    Intellectual Disability, Developmental Disability, Axis I Diagnosis Trial in Boston (Generic Best Practices, Tailored Best

    Unknown status
    • Intellectual Disability
    • +5 more
    • Generic Best Practices
    • Tailored Best Practices
    • Boston, Massachusetts
      Massachusetts General Hospital
    Jan 26, 2021

    COVID-19 Risk Stratification

    Completed
    • Coronavirus
    • Coronavirus Sars-Associated as Cause of Disease Classified Elsewhere
      • Boston, Massachusetts
        Brigham and Women's Hospital
      Nov 26, 2020